US COVID Update: Alaska healthcare worker suffers allergic reaction to Covid-19 vaccine

▴ US COVID Update: Alaska healthcare worker suffers allergic reaction to Covid-19 vaccine
It is common to see adverse vaccine reactions once wider distribution to the general public begins, even if none of these reactions was observed in clinical trials

An Alaska healthcare worker who suffered an allergic reaction to Pfizer's Covid-19 vaccine on Tuesday felt flushed within the first 10 minutes of receiving the vaccine, and later reported symptoms including shortness of breath and elevated heart rate, doctors said Wednesday.

The case is the first allergic reaction to the vaccine to be reported in the US, although health officials said they are expecting the occasional allergic reaction -- and are prepared to treat anyone suffering from one.

"We expected that a side effect like this could occur after reports of anaphylaxis were made in England after people there received the Pfizer-BioNTech Covid-19 vaccine," said Alaska's Chief Medical Officer Dr Anne Zink. "All sites that are approved to provide vaccinations in Alaska must have medications on hand to deal with an allergic reaction and that was the case in Juneau."

The worker was among staff being vaccinated at Bartlett Regional Hospital in Juneau as part of the rollout of Pfizer's vaccine across the country Tuesday.

According to Dr Lindy Jones, an attending physician at Bartlett Memorial Hospital, the worker was initially held in the vaccine monitoring area right after receiving the shot and took a Benadryl. When she reported shortness of breath, she was taken to the emergency room.

When Jones saw her in the hospital, he said she was experiencing shortness of breath and an elevated heart rate and had developed a rash covering her face and torso.

"I was concerned about an anaphylactic reaction so gave her the standard treatment of a dose of intramuscular epinephrine and she responded immediately," Jones told a news briefing. She was also given antihistamines.
She still had an elevated heart rate and was breathing fast -- a sign of an allergic reaction -- so Jones gave her another dose of epinephrine, as well as steroids "which is another standard bread and butter treatment for adverse anaphylactic reactions," he said.

Jones said the worker, who was not further identified to protect her privacy, had no previous history of allergies to vaccines. She is almost recovered after a night in the intensive care unit.

"She was still enthusiastic that she got the vaccine and the benefits it would give her in the future," Jones said.

"This was an instance where the system worked very well," Dr Jay Butler of the US Centers for Disease Control and Prevention told the news briefing.

"This incident was reported last night to the CDC's Vaccine Adverse Event Reporting System (VAERS) database. The State of Alaska Department of Health and Social Services (DHSS) has been in close communication with the CDC, and the agency is providing guidance and support," the state health department said in a statement.

Dr Paul Offit, a member of the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee, said on Wednesday that doctors will have to keep an eye out for allergic reactions to the new vaccine.
"It's the kind of thing that we're obviously going to need to look at," Offit told CNN's Brianna Keilar. He noted there were two reported cases of allergic reaction in Britain, which rolled out the vaccine earlier this month.

"There were obviously several people in the United Kingdom who had had a severe allergic reaction to this vaccine and had a history of a severe allergic reaction," said Offit, who is director of the Vaccine Education Center and professor of paediatrics at Children's Hospital of Philadelphia.

"Currently, the CDC recommendation is that if you ever had a severe allergic reaction to an injectable medical product, you shouldn't get this vaccine," Offit added.

The Asthma and Allergy Foundation of America also noted on Wednesday that the FDA and CDC "are all keeping an eye on" the reported adverse events.

"Recent media reports of reactions to the new Pfizer/BioNTech COVID-19 vaccine, first out of the U.K and now one report in the United States are stirring safety concerns for people with a history of serious allergies. It's important to remember that we still don't have the full details regarding the specifics of any of these reported reactions," Dr Mitchell Grayson, chair of the foundation's medical scientific council said in a written statement on Wednesday.

"We're in the early stages of COVID-19 vaccine rollout. It is common to see adverse vaccine reactions once wider distribution to the general public begins, even if none of these reactions was observed in clinical trials," Grayson said. "Additional vaccines are in the pipeline so there will likely be more options if it is determined that one vaccine works better in certain populations than others. It's important to let the science do its work, not the headlines. Anyone with concerns about allergy risk should consult with their doctor."

Story Source: https://edition.cnn.com/2020/12/16/health/alaska-allergic-reaction-coronavirus-pfizer-vaccine/index.html 

Tags : #UnitedStates #LatestVaccinationUpdate17thDec #LatestCOVIDNews17thDec #PfizersCovid-19Vaccine #AdverseReactionofCOVIDVaccine #AllergicReactionofCOVIDVaccine #UnitedKingdom #CDC

About the Author


Team Medicircle

Related Stories

26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
23 Jan

Why India’s Vaccine Industry Struggles to Fund Innovation Despite Global Demand

Affordability ensures accessibility, but innovation determines its effectiveness. India, as a global leader in vaccine production, has a responsibility to balance these two aspects.

View
15 Nov

A Preventable Catastrophe: Why Are Children Still Dying from Measles?

Governments must step up their efforts, healthcare systems must become more resilient, and communities must rally together to protect their children.

View
09 Nov

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for all.

View
10 Oct

Go Cheese Announces Strategic Collaboration with Bigg Boss Season 18 to Enhance Brand Engagement and Consumer Reach Across India

Go Cheese, a leading brand from the house of Parag Milk Foods, announces its collaboration with Bigg Boss Season 18

View
06 Sep

The Complex Battle Against Polio: How India’s Vaccination Efforts Address Rare Vaccine-Derived Cases

Vaccine-derived poliovirus cases are extremely rare but can occur when the weakened strain of the poliovirus contained in the oral polio vaccine (OPV) mutates and regains its ability to cause disease.

View
16 Aug

A Giant Leap in India’s Fight Against Dengue: Phase 3 Vaccine Trial Launched

This trial not only aims to protect the population but also reinforces India’s capability to produce cutting-edge healthcare solutions, furthering the nation’s goal of self-reliance in essential medical innovations.

View
18 Jul

Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDC

This collaboration, under the Ministry of Skill Development & Entrepreneurship (MSDE), aims to provide specialized, skill-based training to students who aspire to work in the international healthcare sector.

View
19 Apr

10 compelling reasons why choosing right media platform Is important in healthcare

Selecting the right media platform is essential for effectively disseminating healthcare information, building trust and credibility, reaching the target audience, and ultimately improving patient outcomes.

View
15 Mar

Debunking Myths: ICMR Study Disproves COVID Vaccine Link to Sudden Deaths

As India continues its vaccination drive and global outreach, scientific rigor and data-driven policies remain paramount in safeguarding public health amidst the ongoing pandemic.

View

-Advertisements-




Trending Now

Teenagers Are Losing Friends While Chasing Perfection: Here’s WhyMarch 13, 2025
Your Desk Job is Destroying Your Mind: Here’s How to Fight BackMarch 13, 2025
Wow! Momo Disrupts FMCG Cup Noodles Market with 'Desi-Asian Flavours' – A First in IndiaMarch 13, 2025
How India’s Kidney Health Crisis is Growing UnnoticedMarch 13, 2025
Stuck Between the Snooze Button and the Hustle: Entrepreneurs Struggle to Get Quality SleepMarch 13, 2025
Can Coffee Keep You Steady on Your Feet? New Study Reveals the TruthMarch 13, 2025
NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025
Advancing Road Safety Through Clear Vision: VARS 4.0 Sets Bold AgendaMarch 12, 2025
The Deadly Cost of the “Perfect Body”: When Diet Trends Turn FatalMarch 12, 2025
Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset ManagementMarch 11, 2025
TTK Prestige Revolutionizes Cooking with Innovative AirFlip Two-in-One Air Fryer and GrillMarch 11, 2025
Rewriting Immunology: The Discovery That Could Replace Traditional AntibioticsMarch 11, 2025
Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025